Phenibut-Astrapharm 20 tab. (250 mg/1 tab.)

Description

Psychological indicators (attention, memory, speed and accuracy of sensory-motor reactions) improve under the influence of phenibut, unlike the effect of tranquilizers. The drug lengthens the latent period and reduces the duration and severity of nystagmus, has an antiepileptic effect. Does not affect cholinergic and adrenoceptors.

Phenibut-Astrapharm noticeably reduces manifestations of asthenia and vasovegetative symptoms, including headache, a feeling of heaviness in the head. In patients with asthenia and in emotionally unstable persons already from the first days of therapy with the help of phenibut, self-esteem improves, interest and initiative increase, motivation for activity without unwanted sedation or agitation. It has been established that phenibut improves brain bioenergetics.

Indications for taking Phenibut

Asthenic and anxiety-neurotic states (emotional lability, memory impairment, decreased concentration), restlessness, fear, anxiety, obsessive-compulsive neurosis. In children older than 8 years, stuttering, enuresis, tics. Elderly patients have insomnia, night restlessness.

Prevention of stressful conditions, before operations or painful diagnostic studies. Meniere's disease, dizziness associated with dysfunction of the vestibular apparatus, prevention of motion sickness.As an auxiliary agent during the treatment of withdrawal syndrome in alcoholism. Details:

Contraindications

Increased sensitivity to the components of the drug. Acute renal failure.

Interaction with other drugs

Phenibut can be combined with psychotropic drugs by reducing the dose of the drug and the drugs used with it. Phenibut strengthens and prolongs the action of hypnotic, narcotic, neuroleptic and antiparkinsonian drugs.

Peculiarities of using Phenibut

Caution should be observed in patients with pathology of the digestive tract due to the irritating effect of phenibut. Such patients should be prescribed smaller doses. With long-term use, it is necessary to monitor the cellular composition of blood, indicators of liver function.

The drug contains lactose, so patients with rare hereditary forms of galactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome should not use this medicine.

Method of use and dosage

Phenibut-Astrapharm is taken orally before meals. For asthenic and anxiety-neurotic states, adults are prescribed 250-500 mg 3 times a day. The highest single dose for adults is 750 mg, for elderly patients 500 mg.

The course of treatment is 2-3 weeks. If necessary, the course of treatment can be increased to 4-6 weeks.

For children older than 8 years, 250 mg 3 times a day, for children older than 14 years, adult doses.

For vertigo associated with vestibular dysfunction of infectious origin and Meniere's disease, the drug is prescribed at 750 mg 3 times a day for 5-7 days, with a decrease in the severity of vestibular disorders at 250-500 mg 3 times a day for 5-7 days , and then 250 mg once a day for 5 days.

With a relatively mild course of the disease, Phenibut-Astrafarm is used at 250 mg twice a day for 5-7 days, and then at 250 mg once a day for 7-10 days.

For dizziness associated with dysfunction of the vestibular apparatus of vascular and traumatic genesis, Phenibut-Astrafarm is prescribed 250 mg 3 times a day for 12 days.

For the prevention of motion sickness, a dose of 250-500 mg is prescribed once 1 hour before the scheduled start of motion sickness when the first symptoms of motion sickness appear. The effect of phenibut increases when the dose of the drug is increased.

If there are severe manifestations (vomiting and nausea), the use of the drug is ineffective even in a dose of 750-1000 mg.